Skip to content

The Effectiveness of Portable Electronic Vision Enhancement Systems (p-EVES) for Near Vision in Visual Impairment

The Effectiveness of Portable Electronic Vision Enhancement Systems (EVES) in Comparison to Optical Magnifiers for Near Vision Activities in Visual Impairment - The p-EVES Study

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT01701700
Acronym
p-EVES
Enrollment
100
Registered
2012-10-05
Start date
2013-02-28
Completion date
2015-04-30
Last updated
2018-12-04

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Moderate or Severe Vision Impairment, Both Eyes

Keywords

portable electronic magnifiers

Brief summary

Over 1 million people in the UK suffer from untreatable visual impairment, many of them elderly. The major complaint of visually impaired people is their inability to carry out simple tasks, especially those involving reading. It is known that this activity limitation is a major cause of depression in an older population, and it is reflected in reduced quality of life. Low vision clinics, mostly based within hospital ophthalmology departments, dispense optical magnifiers to allow patients to carry out these tasks again, but these devices do have limitations (unusual posture, short working distance, monocular viewing). Although electronic magnifiers have been around since the 1960s, they were initially very large and expensive. Recent advances in technology have brought about an explosion in the number and range of portable and moderately-priced aids, which can be used binocularly, in a natural working position: these are currently not available through the NHS. Evidence is needed as to whether these portable hand-held electronic magnifiers could offer a significant benefit to the majority of patients, and therefore whether they should be routinely dispensed in low vision clinics. The proposed study is a two-arm randomised crossover trial with existing users of optical magnifiers being assigned to use a hand-held electronic magnifier in addition to their existing devices for 2 months. Reading and task performance will be measured with the aid, and compared to the performance with optical aids, and the patient will be asked to report on the comparisons between the aids.

Interventions

PROCEDUREportable electronic magnifier
PROCEDUREoptical aids

Sponsors

National Institute for Health Research, United Kingdom
CollaboratorOTHER_GOV
University of Manchester
CollaboratorOTHER
Cardiff University
CollaboratorOTHER
Bangor University
CollaboratorOTHER
Manchester University NHS Foundation Trust
Lead SponsorOTHER_GOV

Study design

Allocation
RANDOMIZED
Intervention model
CROSSOVER
Primary purpose
TREATMENT
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
18 Years to 95 Years
Healthy volunteers
No

Inclusion criteria

* Patients of Manchester Royal Eye Hospital * Visual impairment secondary to range of stable ocular pathologies (no change in VA \> 2 lines in previous 6 months) * Currently possess a near vision optical magnifying device. * VA \<= 6/30 (\<=0.7 logMAR) and/or log contrast sensitivity \<=1.20

Exclusion criteria

* Current use of personal EVES device * Hearing inadequate to respond to verbal instruction * Habitual language not English * A physical disability preventing the participant from operating the device * A score of less than 19 on the Mini-Mental State Examination

Design outcomes

Primary

MeasureTime frameDescription
usage of magnifiersChange from baseline at 2 months and 4 monthsUse of Manchester Low Vision Questionnaire to quantify device usage
reading speedChange from baseline at 2 months and 4 monthsReading speed using the device assessed by MNREAD test

Secondary

MeasureTime frameDescription
speed of performance of activities of daily livingChange from baseline at 2 months and 4 monthstotal time taken to performance 5 selected activities of daily living using aids if required
difficulty with near vision activitiesChange from baseline at 2 months and 4 monthsUse of NV-VFQ-15 questionnaire to self-rate difficulty in performance of near vision activities
health related quality of lifeChange from baseline at 2 months and 4 monthsUse of EQ-5D and VISQOL questionnaires to self-rate health-related quality of life
well-beingChange from baseline at 2 months and 4 monthsuse of WHO-5 questionnaire to self-rate wellbeing

Countries

United Kingdom

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026